This review evaluates the development and analytical potential of near-field communication (NFC)-enabled wearable chemical sensors for bioanalytical monitoring, including passive, battery-free, energy-buffered, and hybrid-energy architectures. Moving beyond conventional wireless data transmission, we emphasize how NFC-based power delivery and smartphone-interfaced readout interact with circuit design, flexible manufacturing, microfluidic biofluid handling, and target-specific interfacial chemistry. Representative applications in sweat, saliva, wound exudate, ocular fluids, and selected body-interfaced or portable point-of-care systems illustrate how sensing performance is governed by interfacial recognition and signal-transduction chemistry, together with sampling fidelity, reader coupling, calibration stability, and validation strategy. Although NFC-enabled sensors have achieved substantial miniaturization and functional integration, important limitations remain, including constrained power transfer, intermittent rather than truly continuous interrogation, calibration drift, biofouling, inter-device and smartphone-dependent variability, and limited real-world or clinical validation. Emerging directions such as hybrid energy harvesting, simplified analog readout, antifouling interfaces, and sensing-intervention integration offer promising opportunities, but their analytical robustness and translational relevance require rigorous assessment. Overall, this Review provides a chemical and analytical framework for evaluating NFC-enabled wearable sensing platforms and highlights the need for standardized validation before biofluid measurements are assigned clinical significance.
No takes yet. Share an insight, caveat, or question.
Che et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: